alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 10.11



---

|                                                      |                         |                               |  | 
|----------------------------------------------------- | ----------------------- | ----------------------------- |  | 
|Notice of Grant of Stock Options and Option Agreement |                         | Document Sciences Corporation |  | 
|                                                      | ID: 33-0485994          |                               | 
|                                                      | 6339 Paseo Del Lago     |                               | 
|                                                      | Carlsbad, CA 92009-1309 |                               | 

---

|                |  |                |  |             |  | 
|--------------- |  | -------------- |  | ----------- |  | 
|Optionee Name   |  | Option Number: |  | 000         |  | 
|Address         |  | Plan:          |  | 2004        |  | 
|City, State Zip |  |                |  |             |  | 
|                |  | ID:            |  | 000-00-0000 |  | 

---



Effective             , you have been granted a(n) Non-Qualified Stock Option to buy             
shares of Document Sciences Corporation (the Company) stock at $              per share.



The total option price of the shares granted is $



Shares in each period will become fully vested on the date shown.



|       |  |           |  |           |  |           
|------ |  | --------- |  | --------- |  | ----------
|Shares |  | Vest Type |  | Full Vest |  | Expiration
|       |  |           |  |           |  |           
|       |  |           |  |           |  |           

---



By your signature and the Companys signature below, you and the Company agree that these options are granted under and governed by the terms and conditions of the Companys Stock Option Plan as amended and
the Option Agreement, all of which are attached and made a part of this document.



---





|                              |  |     
|----------------------------- |  | ----
|                              |  |     
|Document Sciences Corporation |  | Date
|                              |  |     
|Optionee Name                 |  | Date
DILLON RESERVOIRLatitude: 39.616Longitude: -106.055Elevation: 9023

DILLON RESERVOIR

Courtesy NRCS - Go to Copper Mountain Site Page...



Copper Mountain

Courtesy NRCS - Go to Fremont Pass Site Page...



Fremont Pass

Courtesy NRCS - Go to Grizzly Peak Site Page...



Grizzly Peak

Courtesy NRCS - Go to Hoosier Pass Site Page...



Hoosier Pass

Courtesy NRCS - Go to Loveland Basin Site Page...



Loveland Basin

Courtesy NRCS - Go to Jackwhacker Gulch Site Page...



Jackwhacker Gulch

Courtesy NRCS - Go to Michigan Creek Site Page...



Michigan Creek
EXHIBIT
32.1




CERTIFICATION


OF


PRINCIPAL
EXECUTIVE OFFICER




Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of Manhattan
Pharmaceuticals, Inc. does hereby certify that, to the best of his
knowledge:


(a)      the
Quarterly Report on Form 10-Q of Manhattan Pharmaceuticals, Inc. for the quarter
ended March 31, 2010 (the “Report”) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(b)      information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of Manhattan Pharmaceuticals,
Inc.




Dated:
      May 24, 2010
              /s/ Michael G.
      McGuinnessMichael
      G. McGuinnessPrincipal
      Executive and Financial Officer
Exhibit 32.1

Informational Addendum to Report on Form 10-Q

Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002

Not Filed Pursuant to the Securities Exchange Act of 1934

The undersigned Chief Executive Officer of OYO Geospace Corporation does hereby certify as follows:

Solely for the purpose of meeting the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and solely to the extent this certification may
be applicable to this Report on Form 10-Q, the undersigned hereby certifies that this Report on Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in this
Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of OYO Geospace Corporation.



/s/ Gary D. OwensName:

Gary D. OwensTitle:

Chief Executive OfficerFebruary 6, 2009
#### Huntsville Gas Light Co. v. Court of County Commissioner of Madison County.

Appeal from Madison Circuit Court.

Tried before the Hon. H .0. Speake.

Oscar E. Hundley, for appellant.

Tancred Betts, for appellee.

The Huntsville Gas Light Company filed a petition addressed to the judge of the circuit court of Madison county asking for a writ of *certiorari*to review the decision of the court of county commissioners for Madison county, in the matter of assessment for taxes against the petitioner. It was averred in the petition that the tax commissioner of Madison county had assessed the petitioner with gross receipts for the years 1897 and 1898, and said assessment was made by the tax commissioner without giving any notice to the petitioner; was entered of record without notice; that said assessment was made without authority, and that the petitioner had, prior to the filing of the petition, paid all the taxes that could be exacted of it for the years 1897 and 1898.

There Was a motion made by the court of county commissioners to strike the petition from the file, on the ground that the. appeal should have been taken by the petitioner from the judgment of the court of county' commissioners to the next term of the circuit court, and that the present appeal would not lie. This motion to strike was granted, and from the judgment granting said motion the petitioner prosecutes the present appeal.

The judgment is affirmed on the authority of the *State of Alabama v. Southern Cotton Oil Co.,*124 Ala. 523.

Opinion by

McClellan, C. J.
xml version="1.0" encoding="UTF-8"?


C\_2021133EN.01001201.xml


| | | | |
| --- | --- | --- | --- |
| 16.4.2021 | EN | Official Journal of the European Union | C 133/12 |

---

Prior notification of a concentration

(Case M.10213 – Ravago/Indukern)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 133/10)

1.

On 9 April 2021, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2021133EN.01001201-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Ravago Chemicals S.A., controlled by Ravago S.A. (‘Ravago’, Luxembourg), |

| | |
| --- | --- |
| — | Indukern S.A. (‘Indukern’, Spain). |

Ravago acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Indukern.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | for Ravago: production and distribution of polymers and rubbers, and distribution of third-party chemicals at a global level. |

| | |
| --- | --- |
| — | for Indukern: distribution of third-party speciality chemicals at a global level. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2021133EN.01001201-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10213 – Ravago/Indukern

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2021133EN.01001201-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2021133EN.01001201-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Page 50141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19154]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Catalyze: Product Definition.
    Date: October 27, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA, National Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616, 
<a href="/cdn-cgi/l/email-protection#432e222d2c296d35222f2a3a2235262637372a2f032d2a2b6d242c35"><span class="__cf_email__" data-cfemail="bdd0dcd3d2d793cbdcd1d4c4dccbd8d8c9c9d4d1fdd3d4d593dad2cb">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: August 31, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-19154 Filed 9-3-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Electronically Filed

Intermediate Court of Appeals

CAAP-14-0001252

21-MAY-2015

11:07 AM
EXHIBIT 99.1
                                                                    ------------

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the quarterly report of Classic Bancshares, Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I David B.
Barbour, President and Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.



Date: August 14, 2002                    /s/ David B. Barbour
      ---------------                   -------------------------------------
                                        David B. Barbour
                                        President and Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          52,958
<SECURITIES>                                         0
<RECEIVABLES>                                    3,865
<ALLOWANCES>                                       405  
<INVENTORY>                                      3,575
<CURRENT-ASSETS>                                60,470
<PP&E>                                           2,645
<DEPRECIATION>                                     827
<TOTAL-ASSETS>                                  62,288
<CURRENT-LIABILITIES>                           12,286
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           178
<OTHER-SE>                                      49,625
<TOTAL-LIABILITY-AND-EQUITY>                    62,288
<SALES>                                          9,162
<TOTAL-REVENUES>                                 9,162
<CGS>                                            2,968
<TOTAL-COSTS>                                    2,968
<OTHER-EXPENSES>                                 5,125
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (431)
<INCOME-PRETAX>                                  1,500
<INCOME-TAX>                                       495
<INCOME-CONTINUING>                              1,005
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,005
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .06
        

</TABLE>
STATE OF LOUISIANA

COURT OF APPEAL, FIRST CIRCUIT

JOHNNY COVINGTON

VERSUS

CLARK SAND CO., INC.; CLEMCO

INDUSTRIES CORPORATION F /K/A

CLEMCO SERVICES CORP.; 

DEPENDABLE ABRASIVES, INC.; 

E.D. BULLARD COMPANY; EMPIRE

ABRASIVE EQUIPMENT COMPANY, 

L. P.; LEHIGH HANSON, INC. ( A

SUBSIDIARY OF HEIDELBERG

CEMENT GROUP) F/K/A HANSON

AGGREGATES, INC. F/K/A

HANSON AGGREGATES CENTRAL, 

INC. F /K/A PIONEER SOUTH

CENTRAL, INC. F /K/A PIONEER

CONCRETE OF TEXAS, INC.; 

INGERSOLL-RAND CORPORATION; 

LEROI COMPRESSOR A/K/A

ROTARY

TECHNOLOGIES; 

COMPRESSION

3M COMPANY; 

RUEMELIN MANUFACTURING CO., 

INC.; SAN STORM, INC.; BOB

SCHMIDT MANUFACTURING, INC.; 

SOUTHERN SILICA OF

LOUISIANA, INC.; SPECIALTY

SAND COMPANY; SULLAIR

COMPRESSOR CORPORATION; AND

TXI OPERATIONS, L.P. 

NO. 2023 CW 0973

DECEMBER 4, 2023

In Re: Empire Abrasive Equipment Company, L.P., applying for

supervisory writs, 19th Judicial District Court, 

Parish of East Baton Rouge, No. 649436. 

BEFORE: McCLENDON, HESTER, AND MILLER, JJ. 

WRIT DENIED. 

COURT OF APPEAL, FIRST CIRCUIT

A.s..D

DEPUTY CLERK OF COURT

FO,R THE COURT

PMc

CHH

SMM
**EXHIBIT
12.1**
  **CERTIFICATIONS**
   I, Arnon
Toussia-Cohen, certify that:
  1. I have
reviewed this annual report on Form 20-F of RADCOM Ltd.;
  2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
  3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the company as of, and for,
the periods presented in this report;
  4. The
company’s other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the company and have:
  (a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the company, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
  (b)
Evaluated the effectiveness of the company’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
  (c)
Disclosed in this report any change in the company’s internal control over
financial reporting that occurred during the period covered by the annual report
that has materially affected, or is reasonably likely to materially affect, the
company’s internal control over financial reporting; and
  5. The
company’s other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the company’s
auditors and the audit committee of the company’s board of directors (or persons
performing the equivalent functions):
  (a) All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the company’s ability to record, process, summarize and report
financial information; and
  (b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the company’s internal control over financial
reporting.
  ****Date: March 30,
2005
    By:
    /s/ *Arnon
      Toussia-Cohen*Arnon
      Toussia-CohenChief
      Executive Officer(Principal
      Executive Officer)
[Federal Register Volume 86, Number 177 (Thursday, September 16, 2021)]
[Notices]
[Page 51707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19990]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration #17147 and #17148; NEW YORK Disaster Number NY-
00208]


Presidential Declaration Amendment of a Major Disaster for the 
State of New York

AGENCY: U.S. Small Business Administration.

ACTION: Amendment 1.

-----------------------------------------------------------------------

SUMMARY: This is an amendment of the Presidential declaration of a 
major disaster for the State of New York (FEMA-4615-DR), dated 09/05/
2021. Incident: Remnants of Hurricane Ida. Incident Period: 09/01/2021 
through 09/03/2021.

DATES: Issued on 09/10/2021.
    Physical Loan Application Deadline Date: 11/04/2021.
    Economic Injury (EIDL) Loan Application Deadline Date: 06/06/2022.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance, U.S. Small Business Administration, 409 3rd Street SW, 
Suite 6050, Washington, DC 20416, (202) 205-6734.

SUPPLEMENTARY INFORMATION: The notice of the President's major disaster 
declaration for the State of New York, dated 09/05/2021, is hereby 
amended to include the following areas as adversely affected by the 
disaster:
Primary Counties (Physical Damage and Economic Injury Loans): Nassau.
Contiguous Counties (Economic Injury Loans Only):
    New York: Suffolk.

    All other information in the original declaration remains 
unchanged.

(Catalog of Federal Domestic Assistance Number 59008)

    Esigned--Barbara Carson
Barbara Carson,
Acting Associate Administrator for Disaster Assistance.
[FR Doc. 2021-19990 Filed 9-15-21; 8:45 am]
BILLING CODE 8026-03-P
# C_2021231EN.01000101.xml

| 16.6.2021 | EN | Official Journal of the European Union | C 231/1 |
| --- | --- | --- | --- |

16.6.2021

EN

Official Journal of the European Union

C 231/1

---

Non-opposition to a notified concentration

(Case M.10270 — SMO PSA/CDC/Swissterminal/Euro Rhein Ports JV)

(Text with EEA relevance)

(2021/C 231/01)

On 9 June 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10270. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10270. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Exhibit 32.1

Informational Addendum to Report on Form 10-Q/A

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Not Filed Pursuant to the Securities Exchange Act of 1934

The undersigned President and Chief Executive Officer of Geospace Technologies Corporation does hereby certify as follows:

Solely for the purpose of meeting the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and solely to the extent this
certification may be applicable to this Report on Form 10-Q/A, the undersigned hereby certifies that this Report on Form 10-Q/A fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information
contained in this Report on Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of Geospace Technologies Corporation.



/s/ Walter R. WheelerName:

Walter R. WheelerTitle:

President and Chief Executive OfficerMay 2, 2014
PROVO RIVER NEAR CHARLESTON, UTLatitude: 40.484Longitude: -111.464Elevation: 5434

PROVO RIVER NEAR CHARLESTON, UT

Courtesy NRCS - Go to Wolf Creek Peak Site Page...



Wolf Creek Peak

Courtesy NRCS - Go to Atwater Site Page...



Atwater

Courtesy NRCS - Go to Beaver Divide Site Page...



Beaver Divide

Courtesy NRCS - Go to Brighton Site Page...



Brighton

Courtesy NRCS - Go to Thaynes Canyon Site Page...



Thaynes Canyon

Courtesy NRCS - Go to Trial Lake Site Page...



Trial Lake